Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/16/2003 First Published: 4/1/2001


1.		Phase II Randomized Study of Monoclonal Antibody Hu1D10 in Patients With Relapsed or Refractory Grade I, II, or III B-Cell Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				PDL-1D10-901 CUMC-0101-552, NCT00014664

Last Modified: 4/11/2003 First Published: 2/21/2003


2.		Phase II Study of Monoclonal Antibody Hu1D10 in Patients With Recurrent Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				SUMC-NCI-1951 NCT00055783

Last Modified: 4/20/2007 First Published: 7/23/2004


3.		Phase II Study of Apolizumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Noncontiguous Stage II or Stage III or IV Small Lymphocytic Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				CLLRC-OSU-0410 6257, NCI-6257, OSU-0410, NCT00089154

Last Modified: 5/1/2001 First Published: 11/1/1999


4.		Phase I Study of Monoclonal Antibody Hu1D10 in Patients With Recurrent Non-Hodgkin's Lymphoma (Summary Last Modified 05/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				UIHC-UICC-LW-02 NCI-T99-0019, NCT00004101, T99-0019

Last Modified: 5/9/2006 First Published: 6/1/2001


5.		Phase I Study of Monoclonal Antibody Hu1D10 in Patients With Previously Treated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				OSU-00H0230 OSU-0101, NCI-1254, NCT00017472, 1254

Last Modified: 10/10/2008 First Published: 10/1/2001


6.		Phase I Study of Apolizumab and Rituximab in Patients With Relapsed CD20 and 1D10-Positive B-Cell Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				NCI-01-C-0235 NCI-2410, 2410, NCT00029367

Last Modified: 12/9/2002 First Published: 11/24/2002


7.		Phase I Study of Monoclonal Antibody Hu1D10 and Filgrastim (G-CSF) in Patients With B-Cell Lymphoproliferative Disorders

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				MAYO-MC0016 NCI-2470, 2470

Select All on One Page